CBBT

Cerebain Biotech (PK) Stock Price

0.0145
0.0003 (2.11%)
0.0145
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Cerebain Biotech Corporation New (PK) CBBT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0003 2.11% 0.0145 13:50:26
Open Price Low Price High Price Close Price Previous Close
0.0145 0.014 0.0159 0.0142
Bid Price Ask Price Spread News
0.0145 0.0157 0.0012 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
181 6,156,426 $ 0.014722 $ 90,633 36,190,637 0.0002 - 0.0278
Last Trade Time Type Quantity Stock Price Currency
13:54:50 11,605 $ 0.0145 USD

Cerebain Biotech (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.01M 643.83M 4.04M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Cerebain Biotech (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CBBT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.0190.01910.01350.015974212,503,854-0.0045-23.68%
1 Month0.02470.02780.01020.017372319,053,993-0.0102-41.3%
3 Months0.00310.02780.00170.012661526,459,4110.0114367.74%
6 Months0.00060.02780.00040.008395521,257,0660.01392,316.67%
1 Year0.00080.02780.00020.006131915,378,7950.01371,712.5%
3 Years0.100.3390.00020.004178312,543,142-0.0855-85.5%
5 Years0.901.100.00020.00422519,822,639-0.8855-98.39%

Cerebain Biotech (PK) Description

Cerebain Biotech Corp. was incorporated on December 18, 2007 under the laws of Nevada. The Company is a smaller reporting biomedical company and through its wholly owned subsidiary, Cerebain Operating, Inc., the Company's business revolves around the discovery of products for the treatment of Alzheimer's disease utilizing Omentum. The Company plans to produce products that will include both a medical device solution as well as a synthetic drug solution.


Your Recent History
USOTC
CBBT
Cerebain B..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.